A randomised controlled trial to evaluate the impact of a nurse delivered in-patient pulmonary programme for people in the post-acute phase of stroke recovery.

Not Applicable

• Conditions: Respiratory muscle weakness following stroke; Respiratory; Stroke - Ischaemic; Stroke - Haemorrhagic; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12612001264875
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-12-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Ischaemic or haemorrhagic stroke patients confirmed on imaging, presenting with any symptoms of dysphasia, dysphagia, hemiplegia and has the ability to form a mouth seal to perform spirometry;
2. 55 years of age or older;
3. National Institute Health Stroke Score (NIHSS) between 5-20 and considered suitable for inpatient rehabilitation;
4. Able to engage in a respiratory programme;
5. All participants or their main caregiver must provide and be capable of providing a declaration of Informed Consent;
6. All participants must be English-speaking or provide a family member who can act as an interpreter;
7. Medically stable with potential for improvement; and
8. Male and female, ethnicity.

Exclusion Criteria

1. Medically unstable patients;
2. Unable to give consent or refusing consent;
3. Unable to follow simple commands or instructions;
4. Impaired level of consciousness; and
5. Evidence of significant cognitive impairment (AMTS lower or equal to 7/10).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increased respiratory muscle strength indicated on spirometric measures.<br>Spirometry and measurement of respiratory muscle strength (Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), Maximal Inspiratory Pulmonary function (MIPs) and Maximal Expiratory Pulmonary function (MEPs)[The period of follow-up will last six weeks. Data will be collected at baseline, at two weeks post randomisation and again at six weeks post randomisation. The data will be collected by a research associate. Timepoints: (weeks) 0, 2weeks, 6 weeks.]